Xylem Inc. $XYL Stake Boosted by Trium Capital LLP

Trium Capital LLP grew its stake in shares of Xylem Inc. (NYSE:XYLFree Report) by 46.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 17,403 shares of the industrial products company’s stock after purchasing an additional 5,490 shares during the quarter. Xylem makes up 1.8% of Trium Capital LLP’s portfolio, making the stock its 13th largest holding. Trium Capital LLP’s holdings in Xylem were worth $2,370,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently made changes to their positions in XYL. Schroder Investment Management Group grew its position in shares of Xylem by 2,055.2% during the third quarter. Schroder Investment Management Group now owns 1,192,682 shares of the industrial products company’s stock worth $171,687,000 after acquiring an additional 1,137,342 shares during the last quarter. Swedbank AB grew its position in shares of Xylem by 19.0% during the third quarter. Swedbank AB now owns 5,197,753 shares of the industrial products company’s stock worth $766,669,000 after acquiring an additional 830,821 shares during the last quarter. Voya Investment Management LLC grew its position in shares of Xylem by 544.0% during the third quarter. Voya Investment Management LLC now owns 868,755 shares of the industrial products company’s stock worth $128,141,000 after acquiring an additional 733,860 shares during the last quarter. Balyasny Asset Management L.P. grew its position in shares of Xylem by 346.2% during the third quarter. Balyasny Asset Management L.P. now owns 712,950 shares of the industrial products company’s stock worth $105,160,000 after acquiring an additional 553,152 shares during the last quarter. Finally, Adage Capital Partners GP L.L.C. bought a new position in shares of Xylem during the second quarter worth about $64,407,000. 87.96% of the stock is owned by institutional investors.

Xylem Stock Performance

Shares of XYL opened at $129.57 on Friday. The firm has a 50-day moving average price of $126.58 and a 200 day moving average price of $137.29. The firm has a market capitalization of $31.50 billion, a PE ratio of 33.05, a P/E/G ratio of 1.83 and a beta of 1.18. The company has a quick ratio of 1.28, a current ratio of 1.62 and a debt-to-equity ratio of 0.12. Xylem Inc. has a 52-week low of $104.14 and a 52-week high of $154.27.

Xylem (NYSE:XYLGet Free Report) last announced its earnings results on Tuesday, February 10th. The industrial products company reported $1.42 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.42. Xylem had a net margin of 10.59% and a return on equity of 11.11%. The firm’s revenue was up 6.3% on a year-over-year basis. During the same period last year, the firm posted $1.18 earnings per share. Xylem has set its FY 2026 guidance at 5.350-5.560 EPS. On average, sell-side analysts anticipate that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Xylem Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 24th. Shareholders of record on Tuesday, February 24th were paid a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date of this dividend was Tuesday, February 24th. This is an increase from Xylem’s previous quarterly dividend of $0.40. Xylem’s dividend payout ratio is 43.88%.

Xylem declared that its Board of Directors has initiated a share repurchase plan on Wednesday, February 25th that permits the company to buyback $1.50 billion in shares. This buyback authorization permits the industrial products company to purchase up to 4.8% of its shares through open market purchases. Shares buyback plans are generally an indication that the company’s board believes its stock is undervalued.

Wall Street Analyst Weigh In

XYL has been the subject of several recent research reports. Royal Bank Of Canada lowered their price target on shares of Xylem from $176.00 to $162.00 and set an “outperform” rating for the company in a research report on Wednesday, February 11th. Weiss Ratings lowered Xylem from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday. Stifel Nicolaus decreased their price objective on Xylem from $178.00 to $175.00 and set a “buy” rating for the company in a report on Wednesday, February 11th. UBS Group decreased their price objective on Xylem from $155.00 to $152.00 and set a “buy” rating for the company in a report on Thursday. Finally, Mizuho set a $138.00 price objective on Xylem in a report on Wednesday, February 11th. Nine analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, Xylem currently has an average rating of “Moderate Buy” and an average price target of $155.31.

Check Out Our Latest Report on Xylem

Xylem Profile

(Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Featured Stories

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.